109 related articles for article (PubMed ID: 19583947)
21. Thienopyridone drugs are selective activators of AMP-activated protein kinase beta1-containing complexes.
Scott JW; van Denderen BJ; Jorgensen SB; Honeyman JE; Steinberg GR; Oakhill JS; Iseli TJ; Koay A; Gooley PR; Stapleton D; Kemp BE
Chem Biol; 2008 Nov; 15(11):1220-30. PubMed ID: 19022182
[TBL] [Abstract][Full Text] [Related]
22. AMP-activated protein kinase (AMPK) molecular crossroad for metabolic control and survival of neurons.
Spasić MR; Callaerts P; Norga KK
Neuroscientist; 2009 Aug; 15(4):309-16. PubMed ID: 19359670
[TBL] [Abstract][Full Text] [Related]
23. Regulation of hepatic metabolism by AMPK.
Foretz M; Viollet B
J Hepatol; 2011 Apr; 54(4):827-9. PubMed ID: 21163246
[No Abstract] [Full Text] [Related]
24. Crystal structure of the heterotrimer core of Saccharomyces cerevisiae AMPK homologue SNF1.
Amodeo GA; Rudolph MJ; Tong L
Nature; 2007 Sep; 449(7161):492-5. PubMed ID: 17851534
[TBL] [Abstract][Full Text] [Related]
25. AMPK in Health and Disease.
Steinberg GR; Kemp BE
Physiol Rev; 2009 Jul; 89(3):1025-78. PubMed ID: 19584320
[TBL] [Abstract][Full Text] [Related]
26. Activation of AMP-activated protein kinase (AMPK) inhibits fatty acid synthesis in bovine mammary epithelial cells.
McFadden JW; Corl BA
Biochem Biophys Res Commun; 2009 Dec; 390(3):388-93. PubMed ID: 19747896
[TBL] [Abstract][Full Text] [Related]
27. Cell-Free Assays to Measure Effects of Regulatory Ligands on AMPK.
Fyffe FA; Hawley SA; Gray A; Hardie DG
Methods Mol Biol; 2018; 1732():69-86. PubMed ID: 29480469
[TBL] [Abstract][Full Text] [Related]
28. Recent progress in the identification of adenosine monophosphate-activated protein kinase (AMPK) activators.
Cameron KO; Kurumbail RG
Bioorg Med Chem Lett; 2016 Nov; 26(21):5139-5148. PubMed ID: 27727125
[TBL] [Abstract][Full Text] [Related]
29. Adenosine monophosphate-activated protein kinase inhibits cardiac hypertrophy through reactivating peroxisome proliferator-activated receptor-alpha signaling pathway.
Meng RS; Pei ZH; Yin R; Zhang CX; Chen BL; Zhang Y; Liu D; Xu AL; Dong YG
Eur J Pharmacol; 2009 Oct; 620(1-3):63-70. PubMed ID: 19699196
[TBL] [Abstract][Full Text] [Related]
30. EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells.
Huang CH; Tsai SJ; Wang YJ; Pan MH; Kao JY; Way TD
Mol Nutr Food Res; 2009 Sep; 53(9):1156-65. PubMed ID: 19662644
[TBL] [Abstract][Full Text] [Related]
31. Globular adiponectin inhibits angiotensin II-induced nuclear factor kappaB activation through AMP-activated protein kinase in cardiac hypertrophy.
Wang C; Li L; Zhang ZG; Fan D; Zhu Y; Wu LL
J Cell Physiol; 2010 Jan; 222(1):149-55. PubMed ID: 19780028
[TBL] [Abstract][Full Text] [Related]
32. Structural basis for AMPK activation: natural and synthetic ligands regulate kinase activity from opposite poles by different molecular mechanisms.
Calabrese MF; Rajamohan F; Harris MS; Caspers NL; Magyar R; Withka JM; Wang H; Borzilleri KA; Sahasrabudhe PV; Hoth LR; Geoghegan KF; Han S; Brown J; Subashi TA; Reyes AR; Frisbie RK; Ward J; Miller RA; Landro JA; Londregan AT; Carpino PA; Cabral S; Smith AC; Conn EL; Cameron KO; Qiu X; Kurumbail RG
Structure; 2014 Aug; 22(8):1161-1172. PubMed ID: 25066137
[TBL] [Abstract][Full Text] [Related]
33. Conformational heterogeneity of the allosteric drug and metabolite (ADaM) site in AMP-activated protein kinase (AMPK).
Gu X; Bridges MD; Yan Y; de Waal PW; Zhou XE; Suino-Powell KM; Xu HE; Hubbell WL; Melcher K
J Biol Chem; 2018 Nov; 293(44):16994-17007. PubMed ID: 30206123
[TBL] [Abstract][Full Text] [Related]
34. Structure of an AMPK complex in an inactive, ATP-bound state.
Yan Y; Mukherjee S; Harikumar KG; Strutzenberg TS; Zhou XE; Suino-Powell K; Xu TH; Sheldon RD; Lamp J; Brunzelle JS; Radziwon K; Ellis A; Novick SJ; Vega IE; Jones RG; Miller LJ; Xu HE; Griffin PR; Kossiakoff AA; Melcher K
Science; 2021 Jul; 373(6553):413-419. PubMed ID: 34437114
[TBL] [Abstract][Full Text] [Related]
35. Binding of cordycepin monophosphate to AMP-activated protein kinase and its effect on AMP-activated protein kinase activation.
Wang Z; Wang X; Qu K; Zhu P; Guo N; Zhang R; Abliz Z; Yu H; Zhu H
Chem Biol Drug Des; 2010 Oct; 76(4):340-4. PubMed ID: 20738312
[TBL] [Abstract][Full Text] [Related]
36. Structures of AMP-activated protein kinase bound to novel pharmacological activators in phosphorylated, non-phosphorylated, and nucleotide-free states.
Yan Y; Zhou XE; Novick SJ; Shaw SJ; Li Y; Brunzelle JS; Hitoshi Y; Griffin PR; Xu HE; Melcher K
J Biol Chem; 2019 Jan; 294(3):953-967. PubMed ID: 30478170
[TBL] [Abstract][Full Text] [Related]
37. Identification of Direct Activator of Adenosine Monophosphate-Activated Protein Kinase (AMPK) by Structure-Based Virtual Screening and Molecular Docking Approach.
Huang T; Sun J; Zhou S; Gao J; Liu Y
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28665353
[TBL] [Abstract][Full Text] [Related]
38. AMPK activators: mechanisms of action and physiological activities.
Kim J; Yang G; Kim Y; Kim J; Ha J
Exp Mol Med; 2016 Apr; 48(4):e224. PubMed ID: 27034026
[TBL] [Abstract][Full Text] [Related]
39. Molecular Mechanism of Nucleotide-Dependent Allosteric Regulation in AMP-Activated Protein Kinase.
Ahalawat N; Murarka RK
J Phys Chem B; 2017 Apr; 121(14):2919-2930. PubMed ID: 28345916
[TBL] [Abstract][Full Text] [Related]
40. Structural basis of allosteric and synergistic activation of AMPK by furan-2-phosphonic derivative C2 binding.
Langendorf CG; Ngoei KRW; Scott JW; Ling NXY; Issa SMA; Gorman MA; Parker MW; Sakamoto K; Oakhill JS; Kemp BE
Nat Commun; 2016 Mar; 7():10912. PubMed ID: 26952388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
